Exec Chat: Abbott Invests In Outreach To Underrepresented Populations

Jennifer Jones-McMeans, Divisional Vice President of Global Clinical Affairs at Abbott’s vascular device business, talked to Medtech Insight about her company’s ongoing efforts to diversify patient enrollment in clinical trials by communicating more effectively and compassionately with people in traditionally underrepresented demographic groups.

• Source: Shutterstock

More from Clinical Trials

More from R&D